The presence of inherited thrombophilia further increased this risk. In the study by Penka et al. [26], the JAK2 mutation was detected in 145 patients with MPN, 27.6% of whom had thrombosis, which was significantly higher than those without (8.0%, p=0.001). This evidence concerns the gene JAK2 and myeloproliferative disorder.